[go: up one dir, main page]

NO20012534D0 - Use of parvoviral capsid particles in the inhibition of cell proliferation and migration - Google Patents

Use of parvoviral capsid particles in the inhibition of cell proliferation and migration

Info

Publication number
NO20012534D0
NO20012534D0 NO20012534A NO20012534A NO20012534D0 NO 20012534 D0 NO20012534 D0 NO 20012534D0 NO 20012534 A NO20012534 A NO 20012534A NO 20012534 A NO20012534 A NO 20012534A NO 20012534 D0 NO20012534 D0 NO 20012534D0
Authority
NO
Norway
Prior art keywords
migration
inhibition
cell proliferation
capsid particles
parvoviral capsid
Prior art date
Application number
NO20012534A
Other languages
Norwegian (no)
Other versions
NO20012534L (en
Inventor
Kristina Broliden
Magnus Westgren
Original Assignee
Magnus Westgren
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magnus Westgren filed Critical Magnus Westgren
Publication of NO20012534D0 publication Critical patent/NO20012534D0/en
Publication of NO20012534L publication Critical patent/NO20012534L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20012534A 1998-11-24 2001-05-23 Use of parvoviral capsid particles in the inhibition of cell proliferation and migration NO20012534L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9804022A SE520177C2 (en) 1998-11-24 1998-11-24 Use of empty, non-infectious, recombinant parvoviral capsid particles, or β-antigen-blocking portions thereof, for the manufacture of drugs for inhibiting hematopoietic stem cells
PCT/IB1999/002112 WO2000030668A2 (en) 1998-11-24 1999-11-23 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration

Publications (2)

Publication Number Publication Date
NO20012534D0 true NO20012534D0 (en) 2001-05-23
NO20012534L NO20012534L (en) 2001-06-29

Family

ID=20413393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012534A NO20012534L (en) 1998-11-24 2001-05-23 Use of parvoviral capsid particles in the inhibition of cell proliferation and migration

Country Status (14)

Country Link
EP (1) EP1131085A2 (en)
JP (1) JP2003516927A (en)
KR (1) KR20010080518A (en)
CN (1) CN1328469A (en)
AU (1) AU2566600A (en)
CA (1) CA2352043A1 (en)
CZ (1) CZ20011369A3 (en)
HU (1) HUP0104298A2 (en)
IS (1) IS5931A (en)
MX (1) MXPA01004949A (en)
NO (1) NO20012534L (en)
PL (1) PL348640A1 (en)
SE (1) SE520177C2 (en)
WO (1) WO2000030668A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE345352T1 (en) * 2001-07-10 2006-12-15 Deutsches Krebsforsch COMPOSITION OF A PARVOVIRUS VP1 PROTEIN VARIANT AND AN ARVOVIRUS NS1 PROTEIN FOR INDUCING CYTOLYSIS
PL1791858T3 (en) * 2004-09-24 2010-09-30 Intercell Ag Modified vp1-capsid protein of parvovirus b19
CN101475942B (en) * 2008-11-28 2012-05-23 中国人民解放军第四军医大学 B19 virus VP1 unique region gene
WO2012159006A2 (en) * 2011-05-18 2012-11-22 University Of Florida Research Foundation, Inc. Polypeptides and vectors for targeting her2/neu expressing cells and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005538A1 (en) * 1988-11-14 1990-05-31 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Parvovirus capsids
NL8902301A (en) * 1989-09-14 1991-04-02 Rijksuniversiteit HUMAN PARVOVIRUS B19 PROTEINS, THEIR PRODUCTION AND THEIR USE IN DIAGNOSTIC ASSAYS AND VACCINES.

Also Published As

Publication number Publication date
CN1328469A (en) 2001-12-26
SE520177C2 (en) 2003-06-03
EP1131085A2 (en) 2001-09-12
PL348640A1 (en) 2002-06-03
CA2352043A1 (en) 2000-06-02
IS5931A (en) 2001-05-02
SE9804022D0 (en) 1998-11-24
JP2003516927A (en) 2003-05-20
WO2000030668A9 (en) 2001-04-05
WO2000030668A8 (en) 2000-09-14
HUP0104298A2 (en) 2002-03-28
WO2000030668A2 (en) 2000-06-02
SE9804022L (en) 2000-05-25
WO2000030668A3 (en) 2000-11-09
KR20010080518A (en) 2001-08-22
CZ20011369A3 (en) 2001-10-17
AU2566600A (en) 2000-06-13
MXPA01004949A (en) 2003-03-10
NO20012534L (en) 2001-06-29

Similar Documents

Publication Publication Date Title
DK9700059U1 (en) Apparatus for use in by-pass operations and the use of such apparatus
DE69827239D1 (en) IONIC PERFLUORVINYL COMPOUNDS AND THEIR USE IN CONDUCTIVE MATERIALS
DE69924908D1 (en) Detection and correction of the flooding of fuel cells
NO983147L (en) Use of an antagonist of PPAR- <alfa> and PPAR- <gamma> in the treatment of syndrome X
NO20024682L (en) Combined use of anti-cytokine antibody or antagonists and anti-CD20 in the treatment of B-cell lymphoma
DE69903636D1 (en) COATING COMPOSITION AND RECORDING MEDIUM
DE69925243D1 (en) DATA PROCESSOR AND DATA STORAGE MEDIUM
FI20001709A7 (en) Fast CD and MD adjustment in sheetfed equipment
DE69527307D1 (en) POROUS FINE PARTICLES AND COSMETICS
FI980640A0 (en) Exemption from the aid scheme and the aid scheme
SG66370A1 (en) Cleaning methods of porous surface and semiconductor surface
FI973753A0 (en) Foerfarande Foer maetning av particle i suspension and maetanordning
DE60003389D1 (en) MONOLITHIC COMPOSITION CONTAINING SOLID PARTICLES AND BINDERS
NO984836L (en) Substituted benzylamines and their use in the treatment of depression
GB9814036D0 (en) Materials and methods relating to the induction of apoptosis in target cells
DK199900242A (en) Electrostatic filter and electrostatic filter electrode for use in the same
NO20012534D0 (en) Use of parvoviral capsid particles in the inhibition of cell proliferation and migration
NO20010464D0 (en) Methods and compositions for the treatment of gastroesophrageal reflux syndrome
DE69528571D1 (en) FILLING HOLES AND THE LIKE IN SUBSTRATES
DE69923440D1 (en) IMPROVEMENTS FROM AND IN RELATION TO PARTICULATE DECTORS
FI964809A0 (en) In the case of use of the processing unit
NO984930D0 (en) Procedure for wet crushing and crushing for carrying out the process
DE69812256D1 (en) 7-propyl-benzodiosepin-3-one and its use in perfumery
DK0961604T3 (en) Absorbent surface materials, absorbent articles including the surface material, and the use of the material in absorbent articles
NO20011901D0 (en) Anti-convulsive derivatives useful in the treatment of alcohol dependence and abuse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application